Health

Mylab rolls out conventional kits and devices to enable decentralized diagnostics and empower smaller labs

Mylab Discovery Solutions, India’s leading biotech company, is all set to roll outnewin vitro diagnostic (IVD)medical devices andkits rangeto empower small labs across the country. Thesedevices and reagents, are specially designed to enable small to medium size laboratories and physicians’ clinics to perform diagnoses at their facilities, without having to send samples to central labs or other cities, which increases the risk of spoiledsamples and delayed reporting.

 

Small labs, since decades, have been using devices designed forbig labs with high work load. Therefore,labs and physicians with low workload had to collect samples and then send them in batches to central labs which are often not in the same city. This results ina long delay between sample collection and analysis.

 

Mylab is introducing conventional diagnostic solutions to create a decentralized diagnostic ecosystem where the lab near you will be able to offer quality diagnostics at faster turn-around. Labs in semi-urban and rural areas in India can now offer specialised tests to patients. This will help patients from remote areas to access specialised tests easily at their home locations and avail timely treatment.

 

The company is doing this by offering devices which have smaller reagent packs, smaller sample volume requirements, better sensitivity, linearity and are point of care and high throughput.Another interesting technology is that now consumers will be able to a detect accuratelevels of natural vitaminslevels (Biotin) even if an individual is consuming vitamin supplements.

 

“We have understood the gaps in existing offerings by existing IVD players and we are now well- positioned to empowerlaboratories with accelerated, cost-effective conventionalIVD tests that can give results faster to physicianstreating the patient. We plan to offer smaller, value for money packs of reagents for labs to drive volumes as was done by FMCG companieswith their products”, said Rajesh Patel, Executive Director, Mylab.

 

Its range of devices includes ones with haematology, microbiology, immunology, blood grouping and many other applications. The company plans to roll out pan India through its network of distributors, and a highly trained and experienced sales force of more than 150 people.

 

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also
Close
Back to top button